サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1519642

出生前・新生児遺伝子検査市場レポート：製品タイプ、スクリーニング、疾患、エンドユーザー、地域別、2024～2032年

Prenatal and Newborn Genetic Testing Market Report by Product Type, Screening, Disease, End User, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 147 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=153.16円
出生前・新生児遺伝子検査市場レポート：製品タイプ、スクリーニング、疾患、エンドユーザー、地域別、2024～2032年
出版日: 2024年07月01日
発行: IMARC
ページ情報: 英文 147 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の出生前・新生児遺伝子検査市場規模は2023年に60億米ドルに達しました。今後、IMARC Groupは、2024～2032年にかけての成長率（CAGR）は11.5％を示し、2032年には165億米ドルに達すると予測しています。出生前・新生児遺伝子検査市場のシェアは、高度な診断・スクリーニング機器に対する需要の高まり、医療業界の繁栄、新生児における先天奇形や遺伝子異常の有病率の上昇などを背景に、着実な成長を遂げています。

出生前・新生児遺伝子検査市場分析：

主要市場促進要因出生前・新生児遺伝子検査需要の増加と医療産業の成長が出生前・新生児遺伝子検査市場の成長を牽引しています。

主要市場動向：主要動向には、出生前と新生児ケアにおける個別化医療のための遺伝子検査の採用拡大が含まれます。これは出生前・新生児遺伝子検査市場の動向にプラスの影響を与えています。

地理的動向：遺伝子スクリーニングを受ける妊婦の増加により、北米が出生前・新生児遺伝子検査市場の需要をリードしています。アジア太平洋の出生前・新生児遺伝子検査市場予測も成長が見込まれます。

競合情勢：Abbott LaboratoriesとBGI Groupが出生前・新生児遺伝子検査市場の収益を牽引している企業です。

課題と機会：課題には倫理的、法的な考慮が含まれます。最近の出生前・新生児遺伝子検査市場のビジネス機会はAIとML技術の統合にあります。

出生前・新生児遺伝子検査市場の動向：

乳幼児における遺伝子疾患の高い有病率

胎内にいる胎児は、いくつかの遺伝病に冒されています。これらの遺伝性疾患の遺伝パターンは、再発の可能性と妊娠中のリスクの両方を決定する役割を担っています。染色体異常を持つ親、遺伝性疾患の家族歴、遺伝性疾患を持つ他の幼児を持つ赤ちゃんは、遺伝性疾患を持つ可能性が高くなります。乳児は遺伝性疾患に罹患する可能性がかなり高いです。さらに、これらの病気は世界中の乳幼児死亡率の原因となっています。例えば、世界保健機関（WHO）の予測では、世界中で790万人の赤ちゃんが遺伝子異常を持って生まれてくる。したがって、乳幼児における遺伝性疾患の有病率の高さが、出生前・新生児遺伝子検査市場展望を後押ししています。

技術の進歩

出生前・新生児遺伝子検査市場レポートの成長は、主に技術の進歩によるものです。非侵襲的出生前検査や次世代シーケンシングなど、多くの重要な進歩は、正確性と改善された結果を保証する安全要件を維持しながら、スクリーニング手順の質を向上させています。さらに、医療業界は、より広範囲の遺伝子異常を検出・特定するために、これらの技術革新を利用することが強く推奨されます。また、生まれてくる幼児の健康と安全にとって何が最善かを、妊婦の両親が決定できるようになります。さらに、大幅な改良がなされたことで、変換の信憑性と信頼性が高まった。

認知度と需要の増加

出生前・新生児遺伝子検査市場概要は、出生前・新生児遺伝子検査に対する認識と需要の高まりにより、驚異的な拡大を経験しています。最近では、早期遺伝子スクリーニングの価値が、妊婦の両親や医療専門家を含むより多くの人々に認識されるようになっています。その結果、イノベーションに対する市場のニーズが高まっています。この技術革新を利用することで、人はまだ存在している遺伝子異常を知り、赤ちゃんの命へのリスクを減らすためにタイムリーな予防措置をとることができます。生まれてくる幼児の健康と安全に関して、妊娠中の両親は最善の決断を下すことができます。世界中の研究者や投資家が、その需要の高まりから検査サービスに注目しています。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブ概要

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の出生前・新生児遺伝子検査市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品タイプ別

  • 消耗品
  • 機器

第7章 市場内訳：スクリーニング別

  • 非侵襲的出生前検査
  • 絨毛膜絨毛採取
  • 羊水穿刺
  • 母体血清スクリーニング

第8章 市場内訳：疾患別

  • ダウン症候群
  • フェニルケトン尿症
  • 嚢胞性線維症
  • 鎌状赤血球貧血

第9章 市場内訳：エンドユーザー別

  • 病院
  • 産科・専門クリニック
  • 診断センター

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 促進要因、抑制要因、機会

  • 概要
  • 促進要因
  • 抑制要因
  • 機会

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • BGI Group
    • Bio-Rad Laboratories Inc.
    • F. Hoffmann-La Roche AG
    • Illumina Inc.
    • Laboratory Corporation of America Holdings
    • Natera Inc.
    • PerkinElmer Inc.
    • Quest Diagnostics Incorporated
    • Ravgen Inc.
図表

List of Figures

  • Figure 1: Global: Prenatal and Newborn Genetic Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Prenatal and Newborn Genetic Testing Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Prenatal and Newborn Genetic Testing Market: Breakup by Product Type (in %), 2023
  • Figure 5: Global: Prenatal and Newborn Genetic Testing Market: Breakup by Screening (in %), 2023
  • Figure 6: Global: Prenatal and Newborn Genetic Testing Market: Breakup by Disease (in %), 2023
  • Figure 7: Global: Prenatal and Newborn Genetic Testing Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Prenatal and Newborn Genetic Testing Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Prenatal and Newborn Genetic Testing (Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Prenatal and Newborn Genetic Testing (Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Prenatal and Newborn Genetic Testing (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Prenatal and Newborn Genetic Testing (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Prenatal and Newborn Genetic Testing (Non-invasive Prenatal Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Prenatal and Newborn Genetic Testing (Non-invasive Prenatal Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Prenatal and Newborn Genetic Testing (Chorionic Villus Sampling) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Prenatal and Newborn Genetic Testing (Chorionic Villus Sampling) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Prenatal and Newborn Genetic Testing (Amniocentesis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Prenatal and Newborn Genetic Testing (Amniocentesis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Prenatal and Newborn Genetic Testing (Maternal Serum Screening) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Prenatal and Newborn Genetic Testing (Maternal Serum Screening) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Prenatal and Newborn Genetic Testing (Downs Syndrome) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Prenatal and Newborn Genetic Testing (Downs Syndrome) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Prenatal and Newborn Genetic Testing (Phenylketonuria) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Prenatal and Newborn Genetic Testing (Phenylketonuria) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Prenatal and Newborn Genetic Testing (Cystic Fibrosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Prenatal and Newborn Genetic Testing (Cystic Fibrosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Prenatal and Newborn Genetic Testing (Sickle Cell Anemia) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Prenatal and Newborn Genetic Testing (Sickle Cell Anemia) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Prenatal and Newborn Genetic Testing (Hospital) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Prenatal and Newborn Genetic Testing (Hospital) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Prenatal and Newborn Genetic Testing (Maternity and Specialty Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Prenatal and Newborn Genetic Testing (Maternity and Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Prenatal and Newborn Genetic Testing (Diagnostic Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Prenatal and Newborn Genetic Testing (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: North America: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: North America: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: United States: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: United States: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Canada: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Canada: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Asia-Pacific: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Asia-Pacific: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: China: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: China: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Japan: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Japan: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: India: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: India: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: South Korea: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: South Korea: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Australia: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Australia: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Indonesia: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Indonesia: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Others: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Others: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Europe: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Europe: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Germany: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Germany: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: France: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: France: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: United Kingdom: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: United Kingdom: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Italy: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Italy: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Spain: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Spain: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Russia: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Russia: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Others: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Others: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Latin America: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Latin America: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Brazil: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Brazil: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Mexico: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Mexico: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Others: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Others: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Middle East and Africa: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Middle East and Africa: Prenatal and Newborn Genetic Testing Market: Breakup by Country (in %), 2023
  • Figure 83: Middle East and Africa: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Global: Prenatal and Newborn Genetic Testing Industry: Drivers, Restraints, and Opportunities
  • Figure 85: Global: Prenatal and Newborn Genetic Testing Industry: Value Chain Analysis
  • Figure 86: Global: Prenatal and Newborn Genetic Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Prenatal and Newborn Genetic Testing Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Prenatal and Newborn Genetic Testing Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Prenatal and Newborn Genetic Testing Market Forecast: Breakup by Screening (in Million US$), 2024-2032
  • Table 4: Global: Prenatal and Newborn Genetic Testing Market Forecast: Breakup by Disease (in Million US$), 2024-2032
  • Table 5: Global: Prenatal and Newborn Genetic Testing Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Prenatal and Newborn Genetic Testing Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Prenatal and Newborn Genetic Testing Market: Competitive Structure
  • Table 8: Global: Prenatal and Newborn Genetic Testing Market: Key Players
目次
Product Code: SR112024A11196

The global prenatal and newborn genetic testing market size reached US$ 6.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 16.5 Billion by 2032, exhibiting a growth rate (CAGR) of 11.5% during 2024-2032. The prenatal and newborn genetic testing market share is experiencing steady growth driven by the growing demand for advanced diagnostic and screening devices, the thriving medical industry, and the rising prevalence of congenital malformations and genetic abnormalities in newborn babies.

Prenatal and Newborn Genetic Testing Market Analysis:

Major Market Drivers: The increasing demand for prenatal and newborn genetic testing and a growing medical industry are driving the prenatal and newborn genetic testing market growth.

Key Market Trends: Key trends include increasing adoption of genetic testing for personalized medicine in prenatal and newborn care. This is positively impacting the prenatal and newborn genetic testing market trends.

Geographical Trends: North America leads the prenatal and newborn genetic testing market demand due to the growing number of pregnant women undergoing genetic screening. The prenatal and newborn genetic testing market forecast for Asia Pacific is also expected to witness growth.

Competitive Landscape: Abbott Laboratories and BGI Group are some of the prenatal and newborn genetic testing market companies driving the prenatal and newborn genetic testing market revenue.

Challenges and Opportunities: Challenges include ethical and legal considerations. The prenatal and newborn genetic testing market recent opportunities lie in the integration of AI and ML technologies.

Prenatal and Newborn Genetic Testing Market Trends:

High Prevalence of Genetic Diseases in Infants

The fetuses in the womb are affected by several genetic disorders. The inheritance pattern of these genetic illnesses has a role in determining both the chance of recurrence and the risk they pose during pregnancy. Babies that have a parent with a chromosomal anomaly, a family history of genetic disorders, or another kid who has a genetic disease are more likely to have genetic diseases. Infants are significantly more likely to be affected by hereditary disorders. Furthermore, these illnesses are to blame for infant mortality worldwide. For example, the World Health Organization predicted that 7.9 million babies worldwide are born with genetic abnormalities. Therefore, the high prevalence of genetic diseases in infants is driving the prenatal and newborn genetic testing market outlook.

Technological advancements

The growth of the prenatal and newborn genetic testing market report is mostly due to advancements in technology. A number of significant advancements, such as non-invasive prenatal testing and next-generation sequencing, have improved the quality of the screening procedure while maintaining safety requirements that guarantee accuracy and improved outcomes. Furthermore, it is highly recommended that the healthcare industry use these innovations to detect and identify a larger range of genetic abnormalities. It also makes sure that the expectant parents decide what's best for the health and safety of their unborn child. Furthermore, a significant improvement has been made, which raises the transformations' authenticity and dependability.

Increasing awareness and demand

The prenatal and newborn genetic testing market overview has experienced an incredible expansion due to the growing awareness and demand for prenatal and newborn genetic testing. These days, the value of early genetic screening is being recognized by more people, including expectant parents and healthcare professionals. The market's need for innovation has increased as a result of this. By using this innovation, a person can learn about genetic abnormalities that are still present and take timely preventative action to reduce the risk to the lives of the babies. With regard to the health and safety of their unborn child, pregnant parents are capable of making the best decisions. Researchers and investors from all over the world have been drawn to the testing services due to their increasing demand.

Prenatal and Newborn Genetic Testing Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the prenatal and newborn genetic testing market statistics, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product type, screening, disease, and end user.

Breakup by Product Type:

Consumables

Instruments

Consumables account for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product type. This includes consumables and instruments. According to the report, consumables represented the largest segment.

Consumables like testing kits and reagents are fueling the prenatal and newborn genetic testing market recent developments. These kits are really important for checking if babies have any genetic problems before they're born or right after they're born. Also, new technology is making these tests better and easier to do. As more people want these tests, the market for the supplies needed for them is growing, too. Doctors need these supplies to offer good genetic testing services. So, these supplies are a big part of why prenatal and newborn genetic testing is becoming more popular and helpful for families.

Breakup by Screening:

Non-invasive Prenatal Testing

Chorionic Villus Sampling

Amniocentesis

Maternal Serum Screening

Non-invasive prenatal testing holds the largest share of the industry

A detailed breakup and analysis of the market based on the screening have also been provided in the report. This includes non-invasive prenatal testing, chorionic villus sampling, amniocentesis, and maternal serum screening. According to the report, non-invasive prenatal testing accounted for the largest market share.

NIPT is the best way to check babies before they're born. It doesn't require taking samples from the womb. It depends on simple blood tests from the mother. This method is safer and more comfortable. It offers accurate results in detecting genetic conditions like Down syndrome. It doesn't involve any complications associated with invasive techniques. Due to these benefits, more expecting parents are opting for NIPT. It's the top choice for prenatal testing as it's convenient, safe, and gives reliable results.

Breakup by Disease:

Downs Syndrome

Phenylketonuria

Cystic Fibrosis

Sickle Cell Anemia

Downs syndrome represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the disease. This includes downs syndrome, phenylketonuria, cystic fibrosis, and sickle cell anemia. According to the report, downs syndrome represented the largest segment.

The largest prenatal and newborn genetic testing market recent price is held by Down syndrome testing. An additional copy of chromosome 21 causes this disorder. It is essential for aspiring parents to get tested for Down syndrome in order to plan for any particular care their child may require. The accuracy and accessibility of Down syndrome diagnostics have increased due to technological breakthroughs. Pregnant women are choosing these tests more frequently in order to protect the health of their unborn child. Furthermore, these examinations are advised by medical professionals as standard prenatal care. There is a large demand for testing, which has led to its dominance in the genetic testing market.

Breakup by End User:

Hospital

Maternity and Specialty Clinics

Diagnostic Centers

Hospital represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospital, maternity and specialty clinics, and diagnostic centers. According to the report, hospital represented the largest segment.

Hospitals are at the top of the market. They are essential in the provision of many medical services, such as genetic testing. Patients seeking genetic testing services prefer hospitals as they are dependable and convenient. Hospitals provide accurate testing and appropriate counselling for patients and their families since they have highly qualified staff and modern facilities. Hospitals also frequently work with medical specialists to provide proper care. People are drawn to hospitals due to their reputation for providing high-quality healthcare services. They thereby lead the market share, confirming their status as the main suppliers of genetic testing services.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest prenatal and newborn genetic testing market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

With a sizable portion of the global market for prenatal and newborn genetic testing, North America currently has a prominent position. The prenatal and newborn genetic testing market has strengthened its position in the region due to a significant number of companies operating in the diagnostics and screening sectors, in addition to the region's increased prevalence of genetic abnormalities and a huge pool of highly aware parents. Also, an increasing number of expecting mothers in this area are having their genetics screened, which supports the market's expansion. The strong purchasing power and growing public knowledge are anticipated to fuel market expansion. For example, March 21st is designated as World Down Syndrome Day each year to raise awareness of the diagnosis and care of individuals with Down syndrome.

Leading Key Players in the Prenatal and Newborn Genetic Testing Industry:

The market for prenatal and newborn genetic testing is expanding rapidly due to the major companies' creativity, innovation, teamwork, and cutting-edge technology. Some of the biggest businesses are constantly working to improve the testing process's quality and safety. The key players are primarily concerned with growing the test panels' capacity to screen for and identify genetic diseases. Additionally, the market for prenatal and newborn genetic testing is expanding at an even faster rate with the help of technological advancements. Furthermore, accessibility and flexibility are guaranteed through partnerships with regulatory bodies and the healthcare industry. Both the expecting parents and their newborns greatly benefit from prenatal and newborn genetic testing.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories

BGI Group

Bio-Rad Laboratories Inc.

F. Hoffmann-La Roche AG

Illumina Inc.

Laboratory Corporation of America Holdings

Natera Inc.

PerkinElmer Inc.

Quest Diagnostics Incorporated

Ravgen Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Latest News:

April 2, 2024: Abbott Laboratories received FDA approval for the TriClip(TM) transcatheter edge-to-edge repair (TEER) system that's designed for the treatment of tricuspid regurgitation (TR).

March 3, 2023: BGI Group partnered with Science Exchange to offer a 5% discount on its Next Generation Sequencing Services.

April 8, 2024: Bio-Rad Laboratories Inc. announces a collaboration with Allegheny Health Network (AHN), a western Pennsylvania-based integrated healthcare system, to generate clinical evidence across a range of cancer types to support the implementation of Bio-Rad's Droplet Digital(TM) PCR (ddPCR(TM)) technology for tumor-informed molecular residual disease (MRD) monitoring of patients with solid tumor cancer following curative-intent treatment.

Key Questions Answered in This Report:

  • How has the global prenatal and newborn genetic testing market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global prenatal and newborn genetic testing market?
  • What is the impact of each driver, restraint, and opportunity on the global prenatal and newborn genetic testing market?
  • What are the key regional markets?
  • Which countries represent the most attractive prenatal and newborn genetic testing market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the prenatal and newborn genetic testing market?
  • What is the breakup of the market based on the screening?
  • Which is the most attractive screening in the prenatal and newborn genetic testing market?
  • What is the breakup of the market based on the disease?
  • Which is the most attractive disease in the prenatal and newborn genetic testing market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the prenatal and newborn genetic testing market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global prenatal and newborn genetic testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Prenatal and Newborn Genetic Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Screening

  • 7.1 Non-invasive Prenatal Testing
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Chorionic Villus Sampling
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Amniocentesis
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Maternal Serum Screening
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Disease

  • 8.1 Downs Syndrome
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Phenylketonuria
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Cystic Fibrosis
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Sickle Cell Anemia
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospital
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Maternity and Specialty Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Diagnostic Centers
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 BGI Group
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Bio-Rad Laboratories Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 F. Hoffmann-La Roche AG
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Illumina Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Laboratory Corporation of America Holdings
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Natera Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 PerkinElmer Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Quest Diagnostics Incorporated
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Ravgen Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.